These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4653197)

  • 1. Acute effects of 6-hydroxyDOPA and its interaction with DOPA on brain amine levels.
    Clarke DE; Smookler HH; Hadinata J; Chi C; Barry H
    Life Sci I; 1972 Feb; 11(3):97-102. PubMed ID: 4653197
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of brain L-dopa concentration with -chymotrypsin.
    Seneca H; Henderson E
    J Am Geriatr Soc; 1973 Jun; 21(6):256-8. PubMed ID: 4710643
    [No Abstract]   [Full Text] [Related]  

  • 4. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 6. L-DOPA: effect on ethanol narcosis and brain biogenic amines in mice.
    Blum K; Calhoun W; Merritt J; Wallace JE
    Nature; 1973 Apr; 242(5397):407-9. PubMed ID: 4735636
    [No Abstract]   [Full Text] [Related]  

  • 7. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 9. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism by dopa of morphine analgesia. A hypothesis for morphine tolerance.
    Vander Wende C; Spoerlein MT
    Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):37-45. PubMed ID: 5030707
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
    Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
    J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the mechanism of action of tetrabenazine as a morphine antagonist II. A participation of catecholamine in the antagonism.
    Takagi H; Nakama M
    Jpn J Pharmacol; 1968 Mar; 18(1):54-8. PubMed ID: 5302461
    [No Abstract]   [Full Text] [Related]  

  • 14. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 15. L-Dopa administration to neonate chicks: effects on behavior and levels of brain biogenic amines.
    Hanig JP; Seifter J
    Experientia; 1971 Feb; 27(2):168-9. PubMed ID: 5549261
    [No Abstract]   [Full Text] [Related]  

  • 16. 6-Hydroxydopa depletion of brain norepinephrine and the function of aggressive behavior.
    Thoa NB; Eichelman B; Richardson JS; Jacobowitz D
    Science; 1972 Oct; 178(4056):75-7. PubMed ID: 4672239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 18. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine: mediator of brain polysome disaggregation after L-dopa.
    Weiss BF; Munro HN; Ordonez LA; Wurtman RJ
    Science; 1972 Aug; 177(4049):613-6. PubMed ID: 4403139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.